Ethinyl Estradiol; Norelgestromin Patent Expiration
Ethinyl Estradiol; Norelgestromin is Used for preventing ovulation in women. It was first introduced by Janssen Pharmaceuticals Inc
Ethinyl Estradiol; Norelgestromin Patents
Given below is the list of patents protecting Ethinyl Estradiol; Norelgestromin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Ortho Evra | US5876746 | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
Nov 20, 2015
(Expired) | Janssen Pharms |
| Ortho Evra | US5972377 | Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
Jun 07, 2015
(Expired) | Janssen Pharms |
Ethinyl Estradiol; Norelgestromin's Family Patents
Explore Our Curated Drug Screens
Ethinyl Estradiol; Norelgestromin Generic API Manufacturers
Several generic applications have been filed for Ethinyl Estradiol; Norelgestromin. The first generic version for Ethinyl Estradiol; Norelgestromin was by Mylan Technologies Inc and was approved on Apr 16, 2014. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Sep 14, 2023.
Given below is the list of companies who have filed for Ethinyl Estradiol; Norelgestromin generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Ethinyl Estradiol; Norelgestromin. This 0.035mg/24hr;0.15mg/24hr version comes by the name ETHINYL ESTRADIOL AND NORELGESTROMIN. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.035MG/24HR; 0.15MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Feb 25, 2021 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
2. MYLAN TECHNOLOGIES
Mylan Technologies Inc has filed for 1 generic for Ethinyl Estradiol; Norelgestromin. This 0.035mg/24hr;0.15mg/24hr version comes by the name XULANE. Given below are the details of the strengths of this generic introduced by Mylan Technologies.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.035MG/24HR; 0.15MG/24HR
(reference standard) | film, extended release | Prescription | TRANSDERMAL | AB | Apr 16, 2014 |
Manufacturing Plant Locations New
Mylan Technologies's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Mylan Technologies as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
3. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Ethinyl Estradiol; Norelgestromin. This 0.035mg/24hr;0.15mg/24hr version comes by the name ONSURA. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.035MG/24HR; 0.15MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Aug 25, 2021 |
4. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Ethinyl Estradiol; Norelgestromin. This 0.035mg/24hr;0.15mg/24hr version comes by the name ETHINYL ESTRADIOL AND NORELGESTROMIN. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.035MG/24HR; 0.15MG/24HR | film, extended release | Prescription | TRANSDERMAL | AB | Sep 14, 2023 |